Prostate Cancer Research Review, Issue 75
In this issue:
First-line talazoparib with enzalutamide in HRR-deficient mCRPC
Actinium-225-PSMA radioligand therapy of mCRPC
Olaparib for mCRPC with alterations in BRCA1 and/or BRCA2
Short- or long-term ADT plus EBRT for high-risk localised prostate cancer
Sociodemographic factors and lethal prostate cancer diagnosis
Stimulated Raman histology interpretation by artificial intelligence
Long-term survival estimates after radical prostatectomy
Addition of cribriform and intraductal carcinoma to CAPRA and NCCN tools
Germline APC I1307K variant and treatment-emergent neuroendocrine prostate cancer
BMI, HbA1c and OS with abirateroneor enzalutamide for mCRPC
Expert contributor
Professor Niall Corcoran
Professor Niall Corcoran is a urological surgeon and translational scientist based in Melbourne. He is Head of the Urology Unit at Western Health and a visiting surgeon at Royal Melbourne and Frankston Hospitals. His group in the University of Melbourne Centre for Cancer Research investigates molecular drivers of prostate cancer metastases and treatment resistance.
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.